This topic contains a solution. Click here to go to the answer

Author Question: Which drug would most likely be an initial treatment for a patient with Alzheimer's disease? 1. ... (Read 47 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Which drug would most likely be an initial treatment for a patient with Alzheimer's disease?
 
  1. Levodopa (Larodopa)
  2. Haloperidol (Haldol)
  3. Benztropine mesylate (Cogentin)
  4. Donepezil hydrochloride (Aricept)

Question 2

The nurse in the emergency department frequently sees clients who have overdosed on acetaminophen (Tylenol). Which client is at highest risk for developing hemolysis?
 
  1. A Native American client
  2. A Jewish client
  3. An African American client
  4. A Caucasian client



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuwy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

4
Rationale 1: Levodopa (Larodopa) is used for Parkinson's disease.
Rationale 2: Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.
Rationale 3: Benztropine mesylate (Cogentin) is used for Parkinson's disease.
Rationale 4: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease.
Global Rationale: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease. Levodopa (Larodopa) and benztropine mesylate (Cogentin) are used for Parkinson's disease. Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.

Answer to Question 2

3
Rationale 1: Native Americans are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 2: Jewish clients are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 3: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol).
Rationale 4: Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Global Rationale: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol). Native Americans, Jewish clients, and Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).





 

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library